Regenics works with GeneScript (US) in the development of WoundClear. 

 

Contact information:

 

Telephone (31) 071-569-0120
Email Sales Inquiries: sales.EU@genscript.com
  Customer Service or Technical Support: support.EU@genscript.com
  Complaints: qa@genscript.com
Fax +31 (0) 85 064 406

 

Regenics AS have developed clinical proof of efficacy and safety  in human 2 degree burn wounds for our products Collex® and Vernex®.

The procudts are beeing developed as class III devices. WoundClear® is developed as a BLA/EU CP biotech drug.